Case Study: Kazmira achieves paperless, cGMP-ready quality control and 96% faster information retrieval with Qualio

How CBD manufacturer Kazmira earned trust in a transitioning market

Kazmira, a Colorado-based manufacturer of hemp-based cannabinoid products, needed to prove regulatory trust and consistent quality in a transitioning cannabis/CBD market. Facing a highly manual, paper-based quality system supported by SharePoint and spreadsheets that couldn’t meet FDA cGMP requirements, Kazmira searched for a digital eQMS and selected Qualio.

Qualio was implemented with structured validation, a train‑the‑trainer approach and document migration, enabling Kazmira to transition to a fully digital quality platform in four weeks. The Qualio eQMS delivered measurable impact—96% reduction in quality information retrieval time, 10 hours saved per week, 99% of employees with up‑to‑date training, over 500 version‑controlled quality documents and a growing library of captured/resolved quality events—while accelerating progress toward FDA 21 CFR 111 compliance and impressing auditors.

Kazmira

Hanna Fanous

Quality Assurance Supervisor